Compare OLLI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLLI | BIO |
|---|---|---|
| Founded | 1982 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.2B |
| IPO Year | 2015 | N/A |
| Metric | OLLI | BIO |
|---|---|---|
| Price | $107.96 | $300.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | $140.69 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 1.3M | 165.1K |
| Earning Date | 12-09-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.35 | N/A |
| EPS | ★ 3.61 | N/A |
| Revenue | $2,537,026,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $18.68 | $1.77 |
| Revenue Next Year | $12.76 | $2.30 |
| P/E Ratio | $30.29 | ★ N/A |
| Revenue Growth | ★ 12.58 | N/A |
| 52 Week Low | $94.88 | $211.43 |
| 52 Week High | $141.74 | $373.69 |
| Indicator | OLLI | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 31.78 | 38.82 |
| Support Level | $109.02 | $298.02 |
| Resistance Level | $118.72 | $319.50 |
| Average True Range (ATR) | 4.99 | 8.41 |
| MACD | -0.97 | -2.21 |
| Stochastic Oscillator | 3.51 | 5.46 |
Ollie's Bargain Outlet Holdings Inc is a retailer of closeout merchandise and excess inventory. The company sells name brand household related items that consumers use in their everyday lives at prices that are heavily discounted below traditional retailers. It offers customers a broad selection of brand name products, including housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.